Top 50 Life Science VC Funds & Investors in Germany (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
7 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $1.1M–$33M |
|
IFB Innovationsstarter
VC Fund
|
5 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
coparion
VC Fund
|
5 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
Lowercarbon Capital
VC Fund
|
3 | United States, United Kingdom, France | Seed, Series A, Series B | Renewable Energy, Energy, Biotechnology | $3.7M–$150M |
|
b.value AG
VC Fund
|
3 | Germany, Poland | Seed, Series A | Biotechnology, Manufacturing, Chemical | $478k–$39M |
|
Elevat3 Capital
VC Fund
|
3 | Germany, United Kingdom | Series A, Series B, Post-IPO Equity | FinTech, Apps, Social | $45M–$157M |
|
IBB Ventures
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$10M |
|
Lima Ventures
VC Fund
|
3 | Turkey, United Kingdom, Estonia | Seed, Pre-Seed | Artificial Intelligence, Software, E-Commerce | $18k–$697k |
|
Grazia Equity
VC Fund
|
3 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
CPT Capital
VC Fund
|
3 | United States, Israel, United Kingdom | Seed, Series A, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Good Seed Ventures
VC Fund
|
3 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $25k–$21M |
|
Agronomics
VC Fund
|
3 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
hiVC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed, Series A | SaaS, Mobile, Rental | $175k–$850k |
|
Ananda Impact Ventures
VC Fund
|
2 | Germany, United Kingdom, Finland | Seed, Series A | Health Care, Software, Information Technology | $1.6M–$18M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$20M |
|
Shine Capital
VC Fund
|
2 | United States, Spain, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $3.5M–$71M |
|
Boost VC
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Software, Artificial Intelligence, Virtual Reality | $100k–$6.6M |
|
Lionheart Ventures
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A | Health Care, Biotechnology, Wellness | $25k–$46M |
|
TechOne VC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed | Software, SaaS, Information Technology | $30k–$2.8M |
|
Chemovator
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Software, Manufacturing, Advanced Materials | $975k–$3.7M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
Inflection
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Pre-Seed | Blockchain, Cryptocurrency, Software | $500k–$13M |
|
Die Brückenköpfe
VC Fund
|
2 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $2M–$19M |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Angel, Pre-Seed | Health Care, Medical Device, Medical | |
|
Investitionsbank Berlin
VC Fund
|
2 | Germany, Canada | Grant, Seed | Software, Information Technology, Artificial Intelligence | $19k–$2.3M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Happiness Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Food and Beverage, Life Science | $2M–$61M |
|
EQT Group
VC Fund
|
2 | Germany | Series A | Life Science, Biotechnology, Food and Beverage | $46M–$50M |
|
Zee Prime Capital
VC Fund
|
2 | United States, Singapore, United Kingdom | Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $1.9M–$43M |
|
1kx
VC Fund
|
2 | United States, Germany, Switzerland | Seed, Series A | Blockchain, Cryptocurrency, Software | $1.8M–$28M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
KfW
VC Fund
|
2 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Teknoloji Yatirim
VC Fund
|
1 | Turkey, United States, Germany | Seed, Series A, Convertible Note | Software, Machine Learning, Analytics | |
|
adesso ventures
VC Fund
|
1 | Germany | Seed, Series A | Software, Information Technology, Health Care | |
|
Qiagen
VC Fund
|
1 | Germany, United States | Seed, Series B | Biotechnology, Medical, Biopharma | |
|
Bool Capital
VC Fund
|
1 | Germany | Seed | Life Science, Biotechnology | |
|
Boom Capital Ventures
VC Fund
|
1 | United States, Canada, France | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | |
|
German Federal Ministry of Education and Research
VC Fund
|
1 | Germany, United States, Denmark | Grant, Seed, Series B | Biotechnology, Medical, Health Care | |
|
Abiomed
VC Fund
|
1 | United States, Germany, Israel | Series B, Series D | Medical Device, Health Care, Medical | |
|
Wille Finance
VC Fund
|
1 | France, Germany, Switzerland | Series A, Seed | Health Care, Software, Biotechnology | |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
1 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | |
|
ATHOS Service
VC Fund
|
1 | Germany | Series A, Series C | Railroad, Software, Biopharma | |
|
EIC Fund
VC Fund
|
1 | Germany, The Netherlands, Austria | Pre-Seed, Seed | Biotechnology, Health Care, Information Technology | |
|
JOT-Berlin
VC Fund
|
1 | Germany | Seed | News, Life Science, Social Media | |
|
Manouchehr Shamsrizis Alma Mater Capital
VC Fund
|
1 | Germany | Pre-Seed | Video Games, Life Science, Therapeutics | |
|
Bayern Kapital
VC Fund
|
1 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | $1.1M–$31M |
|
EQT Ventures
VC Fund
|
1 | Sweden, Germany, United States | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $3.3M–$100M |
|
Possible Ventures
VC Fund
|
1 | Germany, Australia, United States | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $549k–$44M |
|
Seventure Partners
VC Fund
|
1 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.1M–$65M |
| Access all 226 VC funds in Germany Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 583
- Round size: Seed $1.1M–$7.3M; Series A $3.5M–$33M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- DcubeD — Accelerate your space exploration through durable and affordable Release Actuators, Solar Arrays, and Deployables from DCUBED.
- FINE Legal — fine. holt Dir Dein Geld einfach, digital und ohne Risiko.
- NAVAN Technologies — NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yetgentle and non-perturbative manne
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 87
- Round size: Seed $365k–$3M; Grant $80k–$165k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 204
- Round size: Seed $3.7M–$12M; Series A $10M–$50M; Series B $20M–$150M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- Fuse Energy — Fuse Energy is building the future of energy with cheaper tariffs, better service, and greener goals. Switch to Fuse Energy today
- Atana Elements — Atana is a data-driven resource company that accelerates the exploration and development of flowing critical minerals.
b.value AG are into Biotechnology investments.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Chemical
- Stage:Seed, Series A
- Geography: Germany, Poland
Investor stats
- Total investments: 14
- Round size: Seed $478k–$2.5M; Series A $3M–$39M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more...Investment focus
- Industry: FinTech, Apps, Social
- Stage:Series A, Series B, Post-IPO Equity
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 6
- Round size: Series A $45M–$157M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 226
- Round size: Seed $1M–$5.5M; Series A $2.2M–$10M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $33M in 2022
Portfolio highlights
- dentolo — dentolo operates a dental insurance and ecosystem centered around customer needs.With its insurance solution, the company covers 100% in dental, instantly, with best value-for-money, market-leading customer satisfaction and an unmatched modern retail experience within its ecosystem. It addresses consumer demand with dental professionals in 25+regions, reaching 40m+ people nationwide. The company owns proprietary and scalable acquisition channels with the #1 dental guide in DACH and a deeply integrated ecosystem. It relentlessly focuses on customer experience and products that solve real-world pains to make dental care more transparent, affordable, and human.
- Famedly — Der Messenger der Gesundheitsbranche, der auch medizinische Arbeitsprozesse abbildet.
- dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, E-Commerce
- Stage:Seed, Pre-Seed
- Geography: Turkey, United Kingdom, Estonia
Investor stats
- Total investments: 34
- Round size: Seed $18k–$697k; Pre-Seed $50k–$100k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — Heybooster is a provider of analytical tools to ecommerce companies to take better digital marketing decisions.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 83
- Round size: Seed $1.1M–$8M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Patronus Group — Rethinking elderly healthcare
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 59
- Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Xias Bio — Xias Bio is a biotechnology startup specializing in the production of recombinant proteins, offering formulators advanced soluble, active ingredients with improved attributes such as enhanced gel and film formation, as well as antioxidant properties. The company creates non-immunogenic natural motifs to produce a better delivery platform offunctionalities for research, beauty, and healthcare.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $25k–$7M; Series A $6.7M–$21M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 46
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 100
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
hiVC is an early-stage venture capital that connects early-stage startups with winning business models to achieve global success.
Show more...Investment focus
- Industry: SaaS, Mobile, Rental
- Stage:Seed, Pre-Seed, Series A
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 13
- Round size: Seed $175k–$850k; Pre-Seed $200k–$660k
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Kidokit — Kidokit is a child development and parent support application that promotes the growth of infants and kids from one to six years old.
- V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
- HoustonBionics — HoustonBionics is proud to introduce ExoRehab X, a revolutionary at home stroke rehabilitation device to help support recovery.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 72
- Round size: Seed $1.6M–$17M; Series A $3.8M–$18M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $121M in 2022
Portfolio highlights
- DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
- Entelo Bio — Precision Medicine
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 93
- Round size: Series A $2M–$12M; Series B $5.1M–$20M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $94M in 2016
Portfolio highlights
- AYOXXA — AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer,allergies, cardiovascular and infectious diseases – in a single test.
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to build iconic businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 74
- Round size: Seed $3.5M–$18M; Series A $12M–$25M; Series B $10M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
- Mother Games — MOTHER Games is an art and media company that creates transformative experiences through play, blending creativity and innovation to craft unique and engaging interactive experiences.
- Turnout — Turnout Technologies is a technology related company.
Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Virtual Reality
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 287
- Round size: Seed $406k–$6.6M; Pre-Seed $100k–$2.6M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- SKETCHAR.io — Sketchar is the ultimate AR drawing app for art creation, learning to draw, and collaborating with 12M people. Try now!
- Nyad —
- Polkadot — Polkadot is a dedicated community that envisions a web where users own their digital identities and data, restoring their authority.
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk. We do this by supporting the wise development of transformative technologies. Our main areas of investment focus are transformative artificial intelligence and frontier mental health technologies.Leading academics estimate a 1-in-6 chance ofhuman extinction by the year 2100, largely driven by risks from emerging technologies. And now, with the exponential growth of AI, predictions are getting worse. Our startups are part of the solution. We invest in exceptional, ethical founders who are developing transformative technologies that have the potential to impact humanity on a meaningful scale, while generating attractive returns for our LPs.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 39
- Round size: Seed $1.6M–$11M; Series A $25k–$46M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Piramidal — Piramidal offers artificial intelligence software that transforms brain activity into easy-to-understand health data to help diagnose neurological diseases.
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
TechOne VC is a venture capital firm. It invests in innovative tech startups founded by visionary entrepreneurs solving global problems, to deliver superior returns for our investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 59
- Round size: Seed $300k–$2.8M; Pre-Seed $30k–$605k
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $4.4M in 2020
Portfolio highlights
- Co-one — Co-one empowers businesses to unlock the full potential of Generative AI. We provide data-driven solutions for LLM development, including evaluation and dataset generation.
- Getmobil — Getmobill offers services in refurbished devices and their sale and resale.
- Atlas Space —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Chemovator is an incubator of chemistry businesses. It is the business incubator of BASF.
Show more...Investment focus
- Industry: Software, Manufacturing, Advanced Materials
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$3.7M; Pre-Seed $975k–$2.4M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
- Replique — Replique is an online first fully encrypted 3D printing platform that makes spare part management more sustainable to large OEMs.
- Spark e-Fuels — We build technologies for affordable, scalable and sustainable e-fuels production, to enable net-zero aviation today.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 138
- Round size: Seed $2.3M–$17M; Series A $3.8M–$95M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $2M–$13M; Pre-Seed $500k–$4.3M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ubitium — Ubiquitous computing, universal RISC-V microprocessor
- Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
- Fabric Cryptography — Fabric develops a custom cryptography hardware to accelerate cryptography algorithms. The chips, whose components exclusively serve cryptographic purposes, are based on Verifiable Processing Units (VPUs) which incorporate features of GPUs and ASICs to improve the speed and cost of advanced cryptographic workloads.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Seed $2M–$2.1M; Series A $5.5M–$19M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 12
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
Investitionsbank Berlin (IBB) is the subsidy bank of the Federal Land of Berlin. With its newly orientated economic support and subsidy policy, it actively contributes towards developing Berlin as a business and industry location.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Grant, Seed
- Geography: Germany, Canada
Investor stats
- Total investments: 59
- Round size: Seed $598k–$2.3M; Grant $19k–$1.4M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Quantune — Quantune is a deep tech startup in optics and photonics technology. It develops laser spectrometer for continuous and non-invasive health monitoring.
- Level Nine — Level Nine specializes in bio-nanotechnology and quantum chemistry, developing next-generation catalysts known as nanozymes.
- muffintech — Generative AI for the insurance industry. Unleash the full potential of your employees and offer your customers an unmatched user experience.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Life Science
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $2M–$9.3M; Series A $10M–$45M; Series B $8.7M–$61M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
EQT is an investment organization committed to creating value by finding good companies and helping them become the most promising builders of tomorrow.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $46M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Series A
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 84
- Round size: Seed $1.9M–$9M; Series A $2.8M–$43M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Cryopets — Pausing biological time with cryosleep for pets
- Share — Share operates as an independent and neutral digital infrastructure platform dedicated to advancing Africa’s growth and development. It provides reliable, scalable, and inclusive technological foundations that enable governments, businesses, and communities to build, connect, and innovate.
- Ceramic Network — Ceramic Network is a provider of protocols for decentralized and composable data applications. The network decentralizes application databases, making data universally composable and reusable across applications. It consists of three core parts: a highly-scalable, decentralized infrastructure for data availability and consensus, a marketplace ofcommunity-created data models, and a suite of standard APIs for storing, updating, and retrieving data from those models.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!1kx is an early-stage investment firm focused on ecosystem growth.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 162
- Round size: Seed $1.8M–$11M; Series A $6M–$28M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Bluff —
- Cryptio — We offer enterprise-grade accounting, reporting, and audit software for your digital assets.
- Kulipa — Kulipa provides the underlying infrastructure to settle global payments, manage stablecoin accounts, and issue cards - all through a unified, compliant stack. Grow revenue with debit cards. Boost acquisition with white-labelled accounts & cards. Scale faster with global payment products.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 170
- Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- Future Fertility — OUR AI-POWERED ASSESSMENTS GUIDE PERSONALIZED FERTILITY TREATMENT DECISIONS IN OVER 180 CLINICS ACROSS 32 COUNTRIES
- ApoGen Biotechnologies — ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapieseventually fail due to the development of drug resistance. Mutation of cellular DNA is central to the formation of cancer, and chronic mutation of the cancer genome is a primary cause of cancer evolution and drug resistance, resulting in ineffective therapy, cancer recurrence and metastasis, and decreased overall survival.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 158
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — AtlasEdge is an edge data center business with a mission to create the leading-edge platform, delivering seamless, localized and ultra-low latency digital infrastructure to customers. They provide a wide range of direct connectivity options to enable connectivity within their datacenters. All cabling is installed and managed by AtlasEdge and itsengineering team to ensure speed of installation and guaranteed quality and management.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
Teknoloji Yatırım is the first actor investing in early-stage technology companies in Turkey. Aiming at preparing the venture capital ecosystem for new players, Teknoloji Yatırım designs, develops and manages innovative tools to meet the financing needs of technology companies in the early and growth stages. What We Do: - Direct Investments: Wemake equity investments to technology companies having internationalization potential. - Co-Investments and Follow-on Investments: We make co-investments and follow-on investments to technology companies at scaling and growth stages, together with other Venture Capital Funds. - Consultancy Services: We offer consultancy solutions in the design, implementation and management of innovative investment tools and models.
Show more...Investment focus
- Industry: Software, Machine Learning, Analytics
- Stage:Seed, Series A, Convertible Note
- Geography: Turkey, United States, Germany
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Cellsway — Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development ofmicrofluidics and lab-on-a-chip technologies for biomedical purposes.
- BRANDEFENSE — Brandefense platform is a proactive digital risk protection solution for organizations. Our AI-driven technology constantly scans the dark, deep, and surface web.
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
Der Inkubator der adesso Group - Was du brauchst und was wir dir bieten.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Acto — Acto is a SaaS software provider that caters to B2B sales leaders. The company leverages artificial intelligence to automate data analytics, providing valuable insights to sales teams about potential risks and opportunities in account management. Acto's platform is designed to enhance the performance of sales teams and drive business growth.It links all data in one place and proactively informs teams about sales opportunities and risks in their customers. This eliminates the need for lengthy searches in Excel reports and allows for a more streamlined and efficient sales process.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Flowstep — Flowstep is a copilot that helps you create better designs, 10x faster. Just type and get user flows, high-fidelity UI, JTBD and more.
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Seed, Series B
- Geography: Germany, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Actome — Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
- Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
- Coley Pharmaceutical Group — Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changedits name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
Bool Capital is a private investment firm that builds deep-tech ventures in cloud infrastructure, blockchain, cybersecurity.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Boom Capital is a pre-seed fund for deeply technical, under-networked founders trying to build their companies. It was incorporated in 2017 and is based in San Francisco, California.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
- Waypoint Bio — Waypoint's proprietary spatial multi-omics platform enables us to solve critical issues around understanding how cell therapies navigate the three-dimensional tumor microenvironment and allow the measurement of cell-to-cell interactions.
The German Federal Ministry of Education and Research funds research programs and institutions, supervises nuclear energy, and establishes educational policy in general.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Grant, Seed, Series B
- Geography: Germany, United States, Denmark
Investor stats
- Total investments: 58
- Lead/follow: no public data
Portfolio highlights
- NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
- CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's productsare used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Series B, Series D
- Geography: United States, Germany, Israel
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Impulse Dynamics — Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediateand powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance.Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.
- Shockwave Medical — Shockwave Medical is a Cardiovascular Medical Device Company changing how calcified cardiovascular disease is treated with Intravascular Lithotripsy (IVL).
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!An international, Swiss-based family office, focusing on private equity (venture & buy-out), real estate and listed assets.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: France, Germany, Switzerland
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Happydemics — Happydemics is the story of frustration become conviction. A frustration with the complexity of market research, neglected by decision-makers in favor of a simplistic and stereotypical vision of a target. But Happydemics is above all the conviction that they must reinvent the experience of studies for brands, but also for respondents, bydemocratizing access to the opinion of all people. Happydemics was born, and 5 years later, Their conviction is stronger every day!
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 118
- Lead/follow: no public data
Portfolio highlights
- MiViA — From microstructure segmentation to grain size measurement! Our AI engine provides a fast and reliable metallographic analysis for metallic products.}
- BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
- volytica diagnostics — Our software enables customers to develop more economical battery systems, reduce operational risks and establish second-use concepts.
ATHOS Service GmbH is the family office of Thomas und Andreas Strüngmann. ATHOS Service GmbH is based in Munich, Germany.
Show more...Investment focus
- Industry: Railroad, Software, Biopharma
- Stage:Series A, Series C
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KONUX — KONUX combines Machine Learning algorithms and IoT to deliver software-as-a-service solutions for operation, monitoring, and maintenance process automation
- BioNTech — BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates.
start-ups, SMEs, technology, co-investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Germany, The Netherlands, Austria
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Filuta AI — Operationalized Composite Artificial Intelligence
- Resistell AG — Resistell is a antibiotic resistance test.
- iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.
Jot-Berlin is a group of angel investors.
Show more...Investment focus
- Industry: News, Life Science, Social Media
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Holding von Manouchehr Shamsrizi, Gründer
Show more...Investment focus
- Industry: Video Games, Life Science, Therapeutics
- Stage:Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 234
- Round size: Seed $1.1M–$5.9M; Series A $3.9M–$31M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $26M in 2010
Portfolio highlights
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- 4.screen — The Driver Interaction Platform. Connect with drivers in real-time to deliver personalized and targeted campaigns.
- ProGlove — ProGlove makes award-winning wearable wireless barcode scanners using BLE or RF technology for ergonomic and efficient hands-free workflows.
EQT Ventures is a European VC fund with just over €2.3 billion in total capital raised. EQT Ventures I launched in May 2016, with commitments totaling €566 million and a simple mission - to be the kind of VC the team would have liked to have had on their own startup journeys. Recognizing that building and growing a company takes more than justcapital, the EQT Ventures team provides founders with support and advice throughout different stages of growth. EQT Ventures doesn't focus on particular markets or industries, but on bold and ambitious founders who have the grit and determination to build global success stories. EQT Ventures II launched in November 2019, with commitments totaling €660 million. EQT Ventures III launched in 2022, with commitments totaling €1.1 billion, making it the biggest European Venture Capital fund committed to early-stage tech startups. The EQT Ventures team is based across six offices in London, Stockholm, Berlin, Paris, Amsterdam, Paris, and San Francisco, taking a locals-with-locals approach and supporting founders on the ground. Motherbrain, EQT Ventures' in-house-developed artificial intelligence (AI) platform, ensures the team has a data-driven approach and has driven more than $100 million in portfolio company investments.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 255
- Round size: Seed $3.3M–$14M; Series A $6.4M–$44M; Series B $15M–$100M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — raised $1.1B in 2022
Portfolio highlights
- Wolt — Wolt delivers from the best restaurants and stores around you.
- Siilo — Doctolib Connect is a secure medical messenger platform designed for healthcare professionals. Communicate patient data with teams and colleagues.
- Holidu — Holidu is one of the fastest-growing travel tech companies worldwide that aims to finally make the search and booking of vacation rentals easy. Its search engine uses proprietary image recognition technology to compare the prices of millions of rental properties across hundred of websites including Airbnb, Booking.com, and Homeaway. This enablesusers to quickly find the ideal accommodation and to save up to 55% on their bookings. It was founded in 2014 by brothers Johannes and Michael Siebers and is headquartered in Munich, Bayern, Germany.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Australia, United States
Investor stats
- Total investments: 163
- Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.5M–$44M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Eden Brew — Eden Brew is a ground-breaking new way to enjoy dairy products sustainably and nutritiously.
- Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
- InSpacePropulsion Technologies — Cost-effective, robust, and quickly available propulsion solutions, based on 10+ years of R&D and 40 years of combined experience in space propulsion.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 218
- Round size: Series A $3.1M–$24M; Series B $3.3M–$65M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Sentryc — Protect your brand and your products from counterfeiters with Sentryc. We monitor over 120 marketplaces for you and remove potential counterfeits.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Life Science VC funding in Germany at a glance
Stats across 133 deals from 226 investors.
Access all 226 VC funds in Germany Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 226 VC funds investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!